NeoTract Designates Dr. Thomas Chun as UroLift® Center of Excellence
Designation Recognizes Dr. Chun’s Commitment to Exemplary Care, Extensive UroLift® System Experience PLEASANTON, CALIF. (PRWEB) APRIL 20, 2020 NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Thomas Chun, M.D., New Jersey Urology in Cliffside Park, NJ, has[…]
Read more